Expression strength key - Revision history

John at 14:14, 11 July 2023

2023-07-11T14:14:33Z

← Older revision		Revision as of 16:14, 11 July 2023
Line 8:		Line 8:


	<span style="color:navy>Given the fairly subjective nature of the term, the table only records fluorescent intensity if it has diagnostic importance, using the terms '''strg''' (strong/bright fluorescence) or '''wk''' for (weak/dim fluorescence). We use the term '''var''' when the expression can differ markedly within a single case</span>		<span style="color:navy>Given the fairly subjective nature of the term "expression strength", the table only records fluorescent intensity if it has diagnostic importance, using the terms '''strg''' (strong/bright fluorescence) or '''wk''' for (weak/dim fluorescence). We use the term '''var''' when the expression can differ markedly within a single case</span>


	----		----

John at 14:13, 11 July 2023

2023-07-11T14:13:42Z

← Older revision		Revision as of 16:13, 11 July 2023
Line 8:		Line 8:


	<span style="color:navy>Given the fairly subjective nature of the term, the table only records fluorescent intensity if it has diagnostic importance, using the terms '''strg''' (strong/bright fluorescence) or '''wk''' for (weak/dim fluorescence).</span>		<span style="color:navy>Given the fairly subjective nature of the term, the table only records fluorescent intensity if it has diagnostic importance, using the terms '''strg''' (strong/bright fluorescence) or '''wk''' for (weak/dim fluorescence). We use the term '''var''' when the expression can differ markedly within a single case</span>


	----		----

John at 20:44, 18 June 2023

2023-06-18T20:44:25Z

← Older revision		Revision as of 22:44, 18 June 2023
Line 8:		Line 8:


	<~~font~~ style=color:"navy">Given the fairly subjective nature of the term, the table only records fluorescent intensity if it has diagnostic importance, using the terms '''strg''' (strong/bright fluorescence) or '''wk''' for (weak/dim fluorescence).</~~font~~>		<span style="color:navy>Given the fairly subjective nature of the term, the table only records fluorescent intensity if it has diagnostic importance, using the terms '''strg''' (strong/bright fluorescence) or '''wk''' for (weak/dim fluorescence).</span>


	----		----

John at 20:42, 18 June 2023

2023-06-18T20:42:40Z

← Older revision		Revision as of 22:42, 18 June 2023
Line 1:		Line 1:
	----		----

	The term "expression strength" effectively reflects how strongly a molecule is expressed by neoplastic cells. This is based on the intensity of the observed fluorescence. The term can be helpful in flow cytometric diagnosis: For example identifying the characteristically weak expression of CD79b by CLL cells, or the characteristically strong expression of CD25 by the cells of HCL.		The term '''"expression strength"''' effectively reflects how strongly a molecule is expressed by neoplastic cells. This is based on the intensity of the observed fluorescence. The term can be helpful in flow cytometric diagnosis: For example identifying the characteristically weak expression of CD79b by CLL cells, or the characteristically strong expression of CD25 by the cells of HCL.

	----		----
Line 8:		Line 8:


	Given the fairly subjective nature of the term, the table only records fluorescent intensity if it has diagnostic importance, using the terms '''strg''' (strong/bright fluorescence) or '''wk''' for (weak/dim fluorescence).		<font style=color:"navy">Given the fairly subjective nature of the term, the table only records fluorescent intensity if it has diagnostic importance, using the terms '''strg''' (strong/bright fluorescence) or '''wk''' for (weak/dim fluorescence).</font>


	----		----

John at 20:41, 18 June 2023

2023-06-18T20:41:21Z

← Older revision		Revision as of 22:41, 18 June 2023
Line 5:		Line 5:
	----		----

	The term is however associated with some difficulties since antibodies and fluorochromes can differ between laboratories, and the judgment of strong (bright) or weak (dim) exprssion is partly subjective based as there is no gold standard to define expression level.		The term is however associated with some difficulties since antibodies and fluorochromes can differ between laboratories, and the judgment of strong (bright) or weak (dim) exprssion is partly subjective based as there is no gold standard to define expression level. A widely used definition uses the term "dim" when a population of cells are positive for a given antigen, but have a mean fluorescence intensity that is lower than that of a positive normal cell population, or "bright" if fluorescence is higher intensity than the control. The control cell is taken as the most closely related normal population.


			Given the fairly subjective nature of the term, the table only records fluorescent intensity if it has diagnostic importance, using the terms '''strg''' (strong/bright fluorescence) or '''wk''' for (weak/dim fluorescence).

	A widely used definition uses the term "dim" when a population of cells are positive for a given antigen, but have a mean fluorescence intensity that is lower than that of a positive normal cell population, or "bright" if fluorescence is higher intensity than the control. The control cell is taken as the most closely related normal population.

	----		----

John at 20:38, 18 June 2023

2023-06-18T20:38:11Z

← Older revision		Revision as of 22:38, 18 June 2023
Line 1:		Line 1:
	~~Expression strength effectively reflects how strongly a molecule is expressed by neoplastic cells based on the intensity of the observed fluorescence.~~		----

	It can be helpful in flow cytometric diagnosis: ~~e.g.~~ the characteristically weak expression of CD79b by CLL cells, or the characteristically strong expression of CD25 by the cells of HCL		The term "expression strength" effectively reflects how strongly a molecule is expressed by neoplastic cells. This is based on the intensity of the observed fluorescence. The term can be helpful in flow cytometric diagnosis: For example identifying the characteristically weak expression of CD79b by CLL cells, or the characteristically strong expression of CD25 by the cells of HCL.

	It is however associated with some difficulties since antibodies and fluorochromes can differ between laboratories and the judgment is often subjective based on the compartor used. However, as the concept is useful we provide a general statement on expected fluorescence intensity that can be expected for each disorder; it is important to be aware of the lab-~~lab variability and assessment when used for interpretation.~~		----

	~~This group recommended descriptions~~ of ~~antigen distribution are "negative" for antigens not expressed, "positive" for antigens expressed,~~ or "~~partially expressed~~" ~~for antigens that are expressed in~~ a ~~subset of the population in question. The reference for distribution should be an appropriate negative control~~ population~~. The recommended descriptions~~ of ~~antibody fluorescence intensity~~ are ~~"dim"~~ for a ~~uniformly positive population with lower~~ mean fluorescence intensity than a positive normal cell population, "bright" ~~for a uniformly positive population with~~ higher intensity than the control~~, and "heterogeneous" for antigens that show variable expression or a spectrum of expression intensity, as opposed to a tight uniform cluster of events~~. The ~~reference for intensity~~ is the ~~closest~~ normal ~~hematolymphoid~~ population. ~~For example, in B~~-cell chronic lymphocytic leukemia, the appropriate intensity reference population for CD19, CD20, CD22, CD23, and kappa/lambda antigen distribution would be normal polyclonal B lymphocytes. This approach is similar to that described in the instructions for leukemia/lymphoma flow cytometry proficiency testing published by the College of American Pathologists.		The term is however associated with some difficulties since antibodies and fluorochromes can differ between laboratories, and the judgment of strong (bright) or weak (dim) exprssion is partly subjective based as there is no gold standard to define expression level.

			A widely used definition uses the term "dim" when a population of cells are positive for a given antigen, but have a mean fluorescence intensity that is lower than that of a positive normal cell population, or "bright" if fluorescence is higher intensity than the control. The control cell is taken as the most closely related normal population.

			----

John at 14:17, 18 June 2023

2023-06-18T14:17:27Z

← Older revision		Revision as of 16:17, 18 June 2023
Line 4:		Line 4:

	It is however associated with some difficulties since antibodies and fluorochromes can differ between laboratories and the judgment is often subjective based on the compartor used. However, as the concept is useful we provide a general statement on expected fluorescence intensity that can be expected for each disorder; it is important to be aware of the lab-lab variability and assessment when used for interpretation.		It is however associated with some difficulties since antibodies and fluorochromes can differ between laboratories and the judgment is often subjective based on the compartor used. However, as the concept is useful we provide a general statement on expected fluorescence intensity that can be expected for each disorder; it is important to be aware of the lab-lab variability and assessment when used for interpretation.

			This group recommended descriptions of antigen distribution are "negative" for antigens not expressed, "positive" for antigens expressed, or "partially expressed" for antigens that are expressed in a subset of the population in question. The reference for distribution should be an appropriate negative control population. The recommended descriptions of antibody fluorescence intensity are "dim" for a uniformly positive population with lower mean fluorescence intensity than a positive normal cell population, "bright" for a uniformly positive population with higher intensity than the control, and "heterogeneous" for antigens that show variable expression or a spectrum of expression intensity, as opposed to a tight uniform cluster of events. The reference for intensity is the closest normal hematolymphoid population. For example, in B-cell chronic lymphocytic leukemia, the appropriate intensity reference population for CD19, CD20, CD22, CD23, and kappa/lambda antigen distribution would be normal polyclonal B lymphocytes. This approach is similar to that described in the instructions for leukemia/lymphoma flow cytometry proficiency testing published by the College of American Pathologists.

John: Created page with "Expression strength effectively reflects how strongly a molecule is expressed by neoplastic cells based on the intensity of the observed fluorescence. It can be helpful in flow cytometric diagnosis: e.g. the characteristically weak expression of CD79b by CLL cells, or the characteristically strong expression of CD25 by the cells of HCL It is however associated with some difficulties since antibodies and fluorochromes can differ between laboratories and the judgment i..."

2023-06-18T14:15:29Z

Created page with "Expression strength effectively reflects how strongly a molecule is expressed by neoplastic cells based on the intensity of the observed fluorescence. It can be helpful in flow cytometric diagnosis: e.g. the characteristically weak expression of CD79b by CLL cells, or the characteristically strong expression of CD25 by the cells of HCL It is however associated with some difficulties since antibodies and fluorochromes can differ between laboratories and the judgment i..."

New page

Expression strength effectively reflects how strongly a molecule is expressed by neoplastic cells based on the intensity of the observed fluorescence.

It can be helpful in flow cytometric diagnosis: e.g. the characteristically weak expression of CD79b by CLL cells, or the characteristically strong expression of CD25 by the cells of HCL

It is however associated with some difficulties since antibodies and fluorochromes can differ between laboratories and the judgment is often subjective based on the compartor used. However, as the concept is useful we provide a general statement on expected fluorescence intensity that can be expected for each disorder; it is important to be aware of the lab-lab variability and assessment when used for interpretation.